Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F39W5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,983
Award facts
- Contract value 100% obligated
- $12,982.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,982.74 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pens on January 22, 2026, with an ultimate completion date of January 23, 2026. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Zepbound is a semaglutide-based medication indicated for weight management, representing part of the broader pharmaceutical supply requirements for federal military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999 million through December 2031. This primary vehicle enables comprehensive pharmaceutical and medical supply distribution to support military healthcare programs globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The prime contractor's significant scale and established presence in federal pharmaceutical procurement positions it as a critical vendor for the Defense Logistics Agency's medical supply chain operations supporting the Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F39W5?
SPE2DR26F39W5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F39W5 worth?
The government has obligated $12,983 on SPE2DR26F39W5.
Is contract SPE2DR26F39W5 an order under another contract?
Yes. SPE2DR26F39W5 is a delivery order under SPE2DR25D1051, an indefinite delivery contract.
Was contract SPE2DR26F39W5 competed?
The extent of competition for SPE2DR26F39W5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award